Guangli Wang

Dr. Wang has strong expertise in protein engineering and production, bioprocess development, and therapeutic antibody production, with over twenty years of experience in the biotech and biopharma industry. He is currently a Co-founder and General Manager of Euprotein, Inc. Previously he served OriGene as Vice President who steered the company’s production and business of protein department across three facilities globally. At OriGene, he successfully launched the largest human antigen collection that was instrumental to antibody and assay development for both research and diagnostic applications. Prior to joining OriGene, he held the Director and Manager positions in several biotech companies including Laureate Pharma, a protein therapeutics development and manufacturing service company. During his tenure at Laureate Pharma, Dr. Wang was involved extensively in the early development and technology transfer of therapeutic antibody production processes and GMP manufacturing. Dr. Wang received his Ph.D. in Biochemistry from Rutgers and finished his postdoctoral training at Princeton University. Over the years, Dr. Wang has gained a deep understanding of the market of life science products, as well as strong leadership and managerial skills in the biotech industry.